-Down to Earth Death and injury prevention get little attention To address the problem of road safety, the Union Ministry of Road Transport and Highways (MoRTH) has published a draft Road Transport and Safety Bill for public comments and suggestions. If passed by Parliament, it would replace the existing Motor Vehicles Act of 1988. While the bill should be aiming for zero mortality, it has set a target to save 200,000 lives in...

-The Week Shambhu Kumar, 8, quite liked his job as a domestic help in a small town in Assam. He had to mind two children nearly his age, keep an eye on the ducks and be available for chores all day. It wasn't too hard, and he was well fed, too, though he missed his grandmother, a tea garden labourer. One day, some women from the state education department came to the...

-Tehelka Despite the serious toll it takes on women's health, female sterilisation remains the most prevalent form of contraception in India. While memories of the 21 months of Emergency in 1975-77, imposed by the then prime minister Indira Gandhi, survives even today in the minds of Indian men as the fear of forced sterilisation, the country's population control policies have shifted over the years since then to target the politically less...

-The Hindu The world cannot afford to talk about hunger without addressing climate change, food production without sustainability or growth without good nutrition With the world's population predicted to reach 9 billion by 2050, we collectively face a dual challenge: ensuring that everyone will have access to affordable, nutritious food without decimating the earth's natural resources in the process. This is easier said than done. Our current food system is dysfunctional both...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...